PRESS RELEASE published on 08/14/2024 at 15:30, 1 year 5 months ago Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of July 31, 2024 Dassault Systèmes declares number of outstanding shares and voting rights as of July 31, 2024, in compliance with financial regulations. Shareholders reminded to follow declaration procedures Shareholders Voting Rights Outstanding Shares Financial Regulations Dassault Systèmes
BRIEF published on 07/31/2024 at 11:31, 1 year 5 months ago Dassault Systèmes: Disclosure of Trading in Own Shares Euronext Paris Share Repurchase Ordinary Shares Dassault Systèmes Trading Information
PRESS RELEASE published on 07/31/2024 at 11:26, 1 year 5 months ago Dassault Systèmes: disclosure of trading in own shares Dassault Systèmes discloses trading in own shares under the repurchase program authorized by the General Meeting of Shareholders. Detailed information available on their website Trading Own Shares General Meeting Dassault Systèmes Repurchase Program
BRIEF published on 07/25/2024 at 15:18, 1 year 6 months ago Dassault Systèmes: Availability of the 2024 Half-Year Financial Report Financial Report IFRS 2024 Dassault Systèmes 3DEXPERIENCE
PRESS RELEASE published on 07/25/2024 at 15:13, 1 year 6 months ago Dassault Systèmes: Availability of the 2024 Half-year Financial Report Dassault Systèmes announces availability of 2024 Half-Year Financial Report as per IFRS standards on their website. Hard copies also available. About Dassault Systèmes' impact and 3DEXPERIENCE platform Financial Report IFRS Dassault Systèmes 3DEXPERIENCE Platform Virtual Twin Experiences
BRIEF published on 07/09/2024 at 07:04, 1 year 6 months ago Dassault Systèmes adjusts its annual objectives after mixed preliminary results for the 2nd quarter of 2024 Financial Results Dassault Systèmes 2nd Quarter 2024 Annual Objectives
PRESS RELEASE published on 07/09/2024 at 06:59, 1 year 6 months ago Dassault Systèmes Provides Preliminary Second Quarter 2024 Results and Full Year Outlook Dassault Systèmes provides preliminary financial results for Q2 2024 below objectives but EPS in line. Updates FY 2024 outlook with revenue growth at 6%-8% and EPS growth at 8%-11% year-on-year Financial Results Revenue Growth Q2 2024 Dassault Systèmes EPS Outlook
BRIEF published on 07/08/2024 at 15:57, 1 year 6 months ago Dassault Systèmes Announces Share and Voting Rights as of June 30, 2024 Voting Rights Shares Investor Relations Financial Announcement Dassault Systèmes
PRESS RELEASE published on 07/08/2024 at 15:52, 1 year 6 months ago Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of June 30, 2024 Dassault Systèmes declares number of outstanding shares and voting rights as of June 30, 2024, per regulations. Encourages shareholders to refer for threshold crossing declarations Shareholders Voting Rights Outstanding Shares Dassault Systèmes June 30 2024
BRIEF published on 07/04/2024 at 07:04, 1 year 6 months ago Bel Group and Dassault Systèmes Partner to Foster Sustainable Food Industry Digital Transformation Sustainability Artificial Intelligence Food Industry Partnership
Published on 01/30/2026 at 14:00, 2 hours 38 minutes ago CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 8 hours 3 minutes ago Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 8 hours 38 minutes ago Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 14 hours 23 minutes ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 16 hours 38 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/30/2026 at 16:00, 38 minutes ago Form 8.3 - The Vanguard Group, Inc.: Dauch Corporation
Published on 01/30/2026 at 15:57, 40 minutes ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 18:00, 22 hours 38 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 22 hours 53 minutes ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 22 hours 53 minutes ago Cegedim generated LFL revenue growth of 1.1% in 2025
